Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway

por Indramanee, Somsiri, Sawanyawisuth, Kanlayanee, Silsirivanit, Atit, Dana, Paweena, Phoomak, Chatchai, Kariya, Ryusho, Klinhom-on, Nathakan, Sorin, Supannika, Wongkham, Chaisiri, Okada, Seiji, Wongkham, Sopit
Publicado 2019

γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus

por Saengboonmee, Charupong, Sorin, Supannika, Sangkhamanon, Sakkarn, Chomphoo, Surang, Indramanee, Somsiri, Seubwai, Wunchana, Thithuan, Kanyarat, Chiu, Ching-Feng, Okada, Seiji, Gingras, Marie-Claude, Wongkham, Sopit
Publicado 2023

Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs

por Yokomizo-Nakano, Takako, Hamashima, Ai, Kubota, Sho, Bai, Jie, Sorin, Supannika, Sun, Yuqi, Kikuchi, Kenta, Iimori, Mihoko, Morii, Mariko, Kanai, Akinori, Iwama, Atsushi, Huang, Gang, Kurotaki, Daisuke, Takizawa, Hitoshi, Matsui, Hirotaka, Sashida, Goro
Publicado 2023